Xylonix and Invitrocue form strategic clinical alliance to validate new method for combating IL-6 pathologies April 28, 2026 Xylonix and Invitrocue form strategic clinical alliance to validate new method for combating IL-6 pathologies X2-IVQ-annoucement-2026-04-28
